[Clinicopathological features in relapsed diffuse large B-cell lymphoma].

Gong, Y X; Yang, Y F; Feng, Y F; Zhai, B Y; Zhang, X; Zhang, Z H

Gong, Y X; Yang, Y F; Feng, Y F; Zhai, B Y; Zhang, X; Zhang, Z H.

Afiliação

Gong YX; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Yang YF; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Feng YF; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Zhai BY; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Zhang X; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Zhang ZH; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.

Zhonghua Bing Li Xue Za Zhi ; 49(10): 1015-1020, 2020 Oct 08.

Article em Zh | MEDLINE | ID: mdl-32992415

Assuntos

Linfoma Difuso de Grandes Células B/tratamento farmacológico; Idoso; Idoso de 80 Anos ou mais; Antígenos CD20; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Neprilisina; Prognóstico; Estudos Retrospectivos

Palavras-chave

Lymphoma, B-cell; Pathology, clinical; Recurrence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: Zh Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google